Strive, Inc. (United States) (ASST)
27.14
+0.32
(+1.19%)
USD |
NASDAQ |
Sep 04, 16:00
27.08
-0.06
(-0.22%)
After-Hours: 20:00
Strive EPS Diluted (Quarterly) : -3.770 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.770 |
| March 31, 2026 | -4.533 |
| December 31, 2025 | -4.599 |
| September 30, 2025 | -6.198 |
| June 30, 2025 | -3.418 |
| March 31, 2025 | -2.523 |
| December 31, 2024 | -4.512 |
| September 30, 2024 | -8.224 |
| June 30, 2024 | -0.5833 |
| March 31, 2024 | -0.4892 |
| December 31, 2023 | -0.4756 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.4326 |
| June 30, 2023 | -0.4835 |
| March 31, 2023 | -0.3921 |
| December 31, 2022 | -0.085 |
| September 30, 2022 | -0.0342 |
| June 30, 2022 | -0.10 |
| March 31, 2022 | -0.0344 |
| December 31, 2021 | 0.0056 |
| September 30, 2021 | -0.0084 |
| June 30, 2021 | 0.0142 |
| March 31, 2021 | -0.0054 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daxor Corp. | -- |
| Meridian Holdings, Inc. (California) | 0.00 |
| SkyAI, Inc. | -0.3229 |
| Hyperliquid Strategies, Inc. | 2.102 |
| TransMedics Group, Inc. | 0.4057 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -257.60M |
| Revenue (Quarterly) | 0.14M |
| Total Expenses (Quarterly) | 257.74M |
| Enterprise Value | 2.741B |
| Gross Profit Margin (Quarterly) | -1.02K% |
| Profit Margin (Quarterly) | -184.0K% |
| Earnings Yield | -70.38% |
| Normalized Earnings Yield | -57.20 |